Zannettino AC - Search Results

1

Concise review: mesenchymal stromal cells: potential for cardiovascular repair.

Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S. Psaltis PJ, et al. Among authors: zannettino ac. Stem Cells. 2008 Sep;26(9):2201-10. doi: 10.1634/stemcells.2008-0428. Epub 2008 Jul 3. Stem Cells. 2008. PMID: 18599808 Review.

2

MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies.

Filshie RJ, Zannettino AC, Makrynikola V, Gronthos S, Henniker AJ, Bendall LJ, Gottlieb DJ, Simmons PJ, Bradstock KF. Filshie RJ, et al. Among authors: zannettino ac. Leukemia. 1998 Mar;12(3):414-21. doi: 10.1038/sj.leu.2400922. Leukemia. 1998. PMID: 9529137

3

Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells.

Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, Simmons PJ. Gronthos S, et al. Among authors: zannettino ac. J Bone Miner Res. 1999 Jan;14(1):47-56. doi: 10.1359/jbmr.1999.14.1.47. J Bone Miner Res. 1999. PMID: 9893065 Free article.

4

Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.

Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Gronthos S, et al. Among authors: zannettino ac. J Cell Sci. 2003 May 1;116(Pt 9):1827-35. doi: 10.1242/jcs.00369. J Cell Sci. 2003. PMID: 12665563

5

RANKL expression is related to the differentiation state of human osteoblasts.

Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino AC. Atkins GJ, et al. Among authors: zannettino ac. J Bone Miner Res. 2003 Jun;18(6):1088-98. doi: 10.1359/jbmr.2003.18.6.1088. J Bone Miner Res. 2003. PMID: 12817763 Free article.

6

The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.

Pan B, To LB, Farrugia AN, Findlay DM, Green J, Gronthos S, Evdokiou A, Lynch K, Atkins GJ, Zannettino AC. Pan B, et al. Among authors: zannettino ac. Bone. 2004 Jan;34(1):112-23. doi: 10.1016/j.bone.2003.08.013. Bone. 2004. PMID: 14751568

7

Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. Kortesidis A, et al. Blood. 2005 May 15;105(10):3793-801. doi: 10.1182/blood-2004-11-4349. Epub 2005 Jan 27. Blood. 2005. PMID: 15677562 Free article.

8

Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.

Zannettino AC, Farrugia AN, Kortesidis A, Manavis J, To LB, Martin SK, Diamond P, Tamamura H, Lapidot T, Fujii N, Gronthos S. Zannettino AC, et al. Cancer Res. 2005 Mar 1;65(5):1700-9. doi: 10.1158/0008-5472.CAN-04-1687. Cancer Res. 2005. PMID: 15753365

9

Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium.

Martens TP, See F, Schuster MD, Sondermeijer HP, Hefti MM, Zannettino A, Gronthos S, Seki T, Itescu S. Martens TP, et al. Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S18-22. doi: 10.1038/ncpcardio0404. Nat Clin Pract Cardiovasc Med. 2006. PMID: 16501624

10

Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1alpha in patients with multiple myeloma.

Martin SK, Dewar AL, Farrugia AN, Horvath N, Gronthos S, To LB, Zannettino AC. Martin SK, et al. Among authors: zannettino ac. Clin Cancer Res. 2006 Dec 1;12(23):6973-7. doi: 10.1158/1078-0432.CCR-06-0323. Clin Cancer Res. 2006. PMID: 17145816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters